Nectar Lifesciences Limited (NECLIFE.BO)
INR 21.9
(-3.27%)
INR 21.9
(-3.27%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 7.09 Billion INR | 5.43% |
| 2022 | 6.72 Billion INR | 1.93% |
| 2021 | 6.59 Billion INR | 12.24% |
| 2020 | 5.87 Billion INR | -39.86% |
| 2019 | 9.77 Billion INR | 6.49% |
| 2018 | 9.17 Billion INR | 6.81% |
| 2017 | 8.59 Billion INR | 0.56% |
| 2016 | 8.54 Billion INR | 2.14% |
| 2015 | 8.36 Billion INR | 5.78% |
| 2014 | 7.9 Billion INR | 4.29% |
| 2013 | 7.58 Billion INR | 12.19% |
| 2012 | 6.76 Billion INR | 14.3% |
| 2011 | 5.91 Billion INR | 25.6% |
| 2010 | 4.7 Billion INR | 18.8% |
| 2009 | 3.96 Billion INR | 17.62% |
| 2008 | 3.36 Billion INR | 73.81% |
| 2007 | 1.93 Billion INR | 1.06% |
| 2006 | 1.91 Billion INR | 59.19% |
| 2005 | 1.2 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 FY | 7.09 Billion INR | 5.43% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 7.09 Billion INR | 0.0% |
| 2023 Q2 | 6.48 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 6.72 Billion INR | 1.93% |
| 2022 Q2 | 6.85 Billion INR | 0.0% |
| 2022 Q4 | 6.72 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 6.59 Billion INR | 12.24% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 6.59 Billion INR | 0.0% |
| 2021 Q2 | 6.24 Billion INR | 0.0% |
| 2020 Q2 | 9.04 Billion INR | 0.0% |
| 2020 FY | 5.87 Billion INR | -39.86% |
| 2020 Q4 | 5.87 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 9.77 Billion INR | 6.49% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 9.77 Billion INR | 0.0% |
| 2019 Q2 | 9.43 Billion INR | 0.0% |
| 2018 FY | 9.17 Billion INR | 6.81% |
| 2018 Q4 | 9.17 Billion INR | 0.0% |
| 2017 FY | 8.59 Billion INR | 0.56% |
| 2016 FY | 8.54 Billion INR | 2.14% |
| 2015 FY | 8.36 Billion INR | 5.78% |
| 2014 FY | 7.9 Billion INR | 4.29% |
| 2013 FY | 7.58 Billion INR | 12.19% |
| 2012 FY | 6.76 Billion INR | 14.3% |
| 2011 FY | 5.91 Billion INR | 25.6% |
| 2010 FY | 4.7 Billion INR | 18.8% |
| 2009 FY | 3.96 Billion INR | 17.62% |
| 2008 FY | 3.36 Billion INR | 73.81% |
| 2007 FY | 1.93 Billion INR | 1.06% |
| 2006 FY | 1.91 Billion INR | 59.19% |
| 2005 FY | 1.2 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 92.814% |
| NATCO Pharma Limited | 7 Billion INR | -1.235% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -206.732% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -3263.857% |
| Achyut Healthcare Limited | 568 Thousand INR | -1248406.162% |
| Ajanta Pharma Limited | 8.28 Billion INR | 14.391% |
| Alkem Laboratories Limited | 26.61 Billion INR | 73.352% |
| Alpa Laboratories Limited | 136.65 Million INR | -5089.432% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 56.852% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -211.192% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 92.77% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -392.336% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -498.706% |
| Brooks Laboratories Limited | 96.1 Million INR | -7278.694% |
| Divi's Laboratories Limited | 31.84 Billion INR | 77.728% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 88.841% |
| Eris Lifesciences Limited | 1.89 Billion INR | -275.149% |
| FDC Limited | 3.88 Billion INR | -82.353% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 71.781% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -6.385% |
| Granules India Limited | 13 Billion INR | 45.473% |
| Gufic Biosciences Limited | 2 Billion INR | -253.723% |
| Hester Biosciences Limited | 755.81 Million INR | -838.267% |
| Indoco Remedies Limited | 3.53 Billion INR | -100.859% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -6681.142% |
| Ipca Laboratories Limited | 24.71 Billion INR | 71.305% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -4628.622% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -7138.899% |
| Lasa Supergenerics Limited | 190.43 Million INR | -3623.87% |
| Laurus Labs Limited | 18.45 Billion INR | 61.572% |
| Lupin Limited | 49.53 Billion INR | 85.685% |
| Mankind Pharma Limited | 15.53 Billion INR | 54.35% |
| Medicamen Biotech Limited | 593.75 Million INR | -1094.356% |
| Medico Remedies Limited | 163.37 Million INR | -4240.716% |
| Megasoft Limited | - INR | -Infinity% |
| Piramal Pharma Limited | 21.75 Billion INR | 67.409% |
| RPG Life Sciences Limited | 1.01 Billion INR | -602.13% |
| Sigachi Industries Limited | 707.2 Million INR | -902.75% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | 7.04 Billion INR | -0.635% |
| Wanbury Limited | 360.23 Million INR | -1868.597% |
| Windlas Biotech Limited | 621.89 Million INR | -1040.317% |
| ZIM Laboratories Limited | 812.62 Million INR | -772.663% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 79.397% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -549.942% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -2353.412% |
| Bal Pharma Limited | 878.11 Million INR | -707.585% |
| Strides Pharma Science Limited | 11.26 Billion INR | 37.034% |
| Venus Remedies Limited | 1.21 Billion INR | -482.752% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -10.312% |
| Shilpa Medicare Limited | 3.44 Billion INR | -105.594% |
| Aarti Drugs Limited | 4.85 Billion INR | -45.949% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -66.922% |
| Suven Life Sciences Limited | 7.08 Million INR | -99991.955% |
| Ind-Swift Limited | 640.91 Million INR | -1006.467% |
| Valiant Laboratories Limited | 100.15 Million INR | -6980.611% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -41.122% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -97.151% |
| Themis Medicare Limited | 705.74 Million INR | -904.83% |
| Hikal Limited | 3.03 Billion INR | -133.489% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 68.883% |
| Sequent Scientific Limited | 3.46 Billion INR | -104.82% |
| Novartis India Limited | 448.6 Million INR | -1480.81% |
| Wockhardt Limited | 6.4 Billion INR | -10.805% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 45.01% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -27713.135% |
| Neuland Laboratories Limited | 3.5 Billion INR | -102.371% |
| Morepen Laboratories Limited | 2.48 Billion INR | -185.265% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -17682.134% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -473.562% |